Medline NAMIC Angiographic Control Syringes Recall Over Connection Risk
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling certain NAMIC Angiographic Control Syringes due to a potential risk of the syringe rotating adaptor unwinding, which could lead to loose connections during use, affecting 192,690 units distributed worldwide.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 22, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
Medline NAMIC Angiographic Control Syringes Recall
What Happened
Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
Which Products Are Affected
The recall involves the following NAMIC Angiographic Control Syringes:
- SYRINGE,7ML,TR/FR,RA,W/RES,-,P/G, Medline SKU 70083007
- SYRINGE,8ML,TR/FR,RA,W/RES,-,P/G, Medline SKU 70084007
- MTS,SYRINGE,8ML,TR/FR,RA,NO,RES,-,P/G, Medline SKU 70084017
- SYRINGE,7,ML,TR/FR,RA,W/RES,OEM,PG, Medline SKU 80083007
- SYRINGE,8,ML,TR/FR,RA,W/RES,OEM,PG, Medline SKU 80084007
- MTO,SYRINGE,8,ML,TR/FR,RA,NO,RES,OEM,PG, Medline SKU 80084017 A total of 192,690 units are affected. Specific lot numbers include: For SKU 70083007: 0000077029, 0000081537, etc.; for SKU 70084007: 0000078186, 0000081539, etc. (full list as provided). UDI/DI codes and distribution are worldwide, including US nationwide and countries like Canada, Netherlands, and Australia. The official recall number is Z-1713-2026.
What You Should Do
Consumers and healthcare providers should immediately stop using the affected syringes and contact Medline Industries, LP at their address: 3 Lakes Dr, Northfield, IL 60093-2753, for further instructions on returns or refunds. The firm initiated this voluntary recall and notified via methods such as email, fax, letter, press release, telephone, or visit.
Why This Matters
This Class I recall highlights potential serious risks in medical procedures due to possible disconnections, emphasizing the importance of device reliability in healthcare settings.
Source
Attribution: FDA. Recall details can be found via FDA resources using recall number Z-1713-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,837 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 22, 2026.
Frequently Asked Questions
Common questions about this FDA recall.